Search

everythinglearnresearchcommunity

for

Search:↓

Alcoholic solvent improves selectivity in key intermediate for finasteride and dutasteride synthesis.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Finasteride affects prostate weights and pituitary activity differently with age.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Certain Dibenzo derivatives may help treat prostate cancer.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Reduced neurosteroid production increases fear in mice, suggesting potential PTSD treatments.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

New compounds may help treat prostate issues without affecting androgen receptors.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Finasteride exposure harms tadpole reproduction and hormone balance.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.